Open AccessJournal Article
lncRNA MEG3 inhibit proliferation and metastasis of gastric cancer via p53 signaling pathway.
Reads0
Chats0
TLDR
It is found that overexpression of lncRNA MEG3 could decrease the proliferation and metastasis of gastric cancer cells and could also increase the expression of p53.Abstract:
Objective lncRNA MEG3 has been reported as a tumor suppressor gene in many different kinds of cancer, but its role in gastric cancer has not been fully understood. Then, we would like to explore its mechanism in gastric cancer. Patients and methods We first used qRT-PCR to detect the expression of lncRNA MEG3, then CCK8 and wound healing assay were used to detect the effect of lncRNA MEG3 on gastric cancer cells. Western blot assay was used to measure the expression of p53 when lncRNA MEG3 was overexpressed. Results lncRNA MEG3 was highly expressed in the adjacent tissue, compared to the one in gastric cancer tissue. What's more, we also found that overexpression of lncRNA MEG3 could decrease the proliferation and metastasis of gastric cancer cells. Finally, overexpression of lncRNA MEG3 could also increase the expression of p53. Conclusions lncRNA MEG3 could inhibit the proliferation and metastasis of gastric cancer.read more
Citations
More filters
Journal ArticleDOI
LncRNA MEG3 regulates microglial polarization through KLF4 to affect cerebral ischemia-reperfusion injury.
TL;DR: Inhibition of MEG3 can alleviate cerebral I/R injury via regulating the polarization of microglia through KLF4 through regulating Krüppel-like factor 4.
Journal ArticleDOI
lncRNA PCAT19 negatively regulates p53 in non-small cell lung cancer
Xiao-Kai Zhang,Qi-Wen Wang,Ya-Juan Xu,Bao Wang,Chunyi Jia,Lei Wang,Hong-Mei Sun,Hui Zhao,Zhe Wang,Qinguang Zou,Shaolin Sun,Lixin Zhang +11 more
TL;DR: It is demonstrated that PCAT19 negatively regulates the p53 tumor-suppression pathway, promoting cancer cell proliferation in patients with NSCLC.
Journal ArticleDOI
Identification of prognostic biomarkers and drug target prediction for colon cancer according to a competitive endogenous RNA network.
TL;DR: A lncRNA-miRNA-mRNA ceRNA network was constructed and drugs that significantly interact with the core genes identified in colon cancer were predicted using a hypergeometric test and fostamatinib was identified as a targeted drug for colon cancer therapy.
Journal ArticleDOI
FENDRR suppresses cervical cancer proliferation and invasion by targeting miR-15a/b-5p and regulating TUBA1A expression
TL;DR: In this paper, quantitative real-time polymerase chain reaction (qRT-PCR) analysis detected gene expression in tissues and cells, and loss-of-function experiments revealed the biological effects of FENDRR and miR-15a/b-5p on CC cell functions.
Journal ArticleDOI
LncRNA MEG3 inhibits non‑small cell lung cancer via interaction with DKC1 protein
Zhi Yang,Zitong Wang,Yong Duan +2 more
TL;DR: LncRNA MEG3/DKC1 was identified as a novel dual-directional regulatory axis in lung cancer, acting as a promising target for the treatment of lung cancer.